BioHarvest Sciences Inc.
CNVCF
$0.185
$0.000.00%
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 17.78% | 27.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.78% | 27.14% | |||
| Cost of Revenue | 9.31% | 19.91% | |||
| Gross Profit | 30.38% | 39.65% | |||
| SG&A Expenses | -19.38% | 16.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.74% | 19.73% | |||
| Operating Income | 30.19% | -13.41% | |||
| Income Before Tax | 39.40% | -278.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 39.40% | -278.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.40% | -278.99% | |||
| EBIT | 30.19% | -13.41% | |||
| EBITDA | 32.86% | -14.08% | |||
| EPS Basic | 39.34% | -281.25% | |||
| Normalized Basic EPS | 39.47% | -280.00% | |||
| EPS Diluted | 39.34% | -281.25% | |||
| Normalized Diluted EPS | 39.47% | -280.00% | |||
| Average Basic Shares Outstanding | 0.02% | 0.84% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
